drugset / Trial / NCT07222072

Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study

NCT07222072

Phase 4 Recruiting 120 enrolled The Cleveland Clinic
RandomizedParallel-groupQuadruple-blindOther

Summary

The investigators propose a randomized, triple-blinded (patients, investigators, outcomes assessors), placebo-controlled pilot feasibility trial (Methadone to End Narcotic Dependence, MEND trial) to assess the feasibility and safety of postoperative oral methadone in patients undergoing spine surgery and collect preliminary data to inform a larger clinical trial that will test the opioid-sparing effects of methadone at 3 months after spine surgery.

Timeline

Start
2025-11-15
Primary completion
2027-10
Completion
2028-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methadone Other / unclassified 5 mg Oral

Indications

No indication recorded.